- Autoimmune Disorders ConferenceOriginal Date: January 28-29, 2017This discounted package includes all of the individual presentations from the conference, which are listed below.12.0 CEUs (including 11.0 general and 1.0 pharmacy) approved by OBNM
- Autoimmunity Essentials: A Mechanistic OverviewPresenter: Heather Zwickey, PhDOriginal Date: January 28, 2017The development of autoimmune disease is a complex process that varies between individuals. Yet research and clinical observations over the past 30 years have led to many general insights into autoimmunity. The identification of Th17 cells as well as the increased role of oxidative stress involved in pathogenesis has allowed researchers to explore the development and progression of autoimmune reactions. This talk highlights a deeper understanding of autoimmune mechanisms. It will help clinicians develop novel clinical approaches for treatment aimed at reducing autoimmune processes and balancing immunity and tolerance.1.5 general CEUs approved by OBNMAyurvedic Medicine for the Treatment of Autoimmune DisordersPresenter: Shailinder Sodhi, BAMS, NDOriginal Date: January 28, 2017The Ayurvedic model provides a comprehensive medical world view based upon creating balance within the body to promote optimal function and healing. Dr. Shailinder Sodhi discusses how these concepts can be integrated with naturopathic concepts to give practitioners more treatment tools and improved outcomes.He begins with basic explanations of Ayurvedic theory that can add to the understanding of the autoimmune disease model. Dr. Sodhi then discusses various treatment modalities including yoga and breathing techniques but focusing primarily on herbal formulations. The presentation also covers some case studies illustrating how these techniques are used in the clinical setting.1.5 general CEUs approved by OBNMAutoimmunity and Environmental ToxicantsPresenter: Lyn Patrick, NDOriginal Date: January 28, 2017Autoimmune diseases are the third leading cause of morbidity and mortality in the industrialized world, surpassed only by cancer and heart disease. According to Fred Miller, director of the Environmental Autoimmunity Group at the National Institute of Environmental Health Sciences, autoimmune diseases are now recognized as among the leading causes of death for young and middle-aged women in the United States. What more, prevalence rates for some of these illnesses are rising for what Miller says must largely be environmental reasons.1.5 general CEUs approved by OBNMA Truly Naturopathic Approach to Autoimmune Disease: Leaving the Era of Reaction and Entering the New Proactive Era of PredictionPresenter: David M. Brady, ND, DC, CCN, DACBNOriginal Date: January 28, 2017Autoimmune disease is growing at epidemic proportions with a very strong predominance of women being affected. Standard interventions are based on symptom control and immune suppression. This presentation reviews a proactive integrative, systems biology, approach for the naturopath to address disease prediction, prevention and treatment, including various evidence-based modalities. Presentation elements also include an exploration of why females are at such increased risk. The role of estrogen and other hormones, the GI microbiota, food immune reactions, stealth infections and molecular mimicry in autoimmune disease pathogenesis will be explored along with how these may serve as leverage points for naturopathic clinical interventions. The hygiene hypothesis and changes in early environmental antigen exposure are also explored. New opportunities for proactive screening for at risk subjects for autoimmune disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel diseases, diabetes, multiple sclerosis, lupus, and others using emerging predictive antibody testing are also reviewed and discussed from the perspective of the naturopathic doctor.1.5 general CEUs approved by OBNM
Naturopathic Consideration & Treatment of Inflammatory Arthritic ConditionsPresenter: Tyna Moore, ND, DCOriginal Date: January 29, 2017Autoimmune and Inflammatory Arthritis is a special consideration in musculoskeletal pain management. Understanding what these conditions are, how they manifest, what standard of care is, where it fails the patient, and how/where naturopathic medicine can be of benefit is critical in the management of these debilitating disease processes. This lecture includes discussion of when/where therapeutic joint injections may be indicted and red flags to be aware of.1.5 general CEUs approved by OBNMFibromyalgia and Global Pain Syndromes: Proper Diagnosis is Half the CurePresenter: David M. Brady, ND, DC, CCN, DACBNOriginal Date: January 29, 2017Research suggests that “classic” fibromyalgia (FMS) is a central pain processing disorder and does not appear to be a peripheral somatic disorder. Dr. Brady emphasizes the concept that this central-mediated disorder is strongly associated with psychological disorders, including trauma and abuse history, depression, anxiety, irritable bowel syndrome, and sleep disorder. Common mechanisms in-play regarding these concomitant issues and global pain will be fully explored and accurate differential diagnostic and comprehensive naturopathic therapeutic strategies will be discussed in-detail. The concept of “pseudo” or “false” fibromyalgia diagnostic labels are also discussed, to include various organic and functional medical conditions, as well as somatic musculoskeletal conditions, which confound the accurate diagnosis of “classic” FMS will are also presented.1.5 CEUs (including 1.0 general and 0.5 pharmacy) approved by OBNMNaturopathic Integrative Diagnosis and Treatment of Hashimoto ThyroiditisPresenter: Paul Kalnins, ND, MSOM, LAcOriginal Date: January 29, 2017Autoimmune thyroid diseases (AITDs), particularly Hashimoto thyroiditis,are common conditions presenting in naturopathic practices. In this seminar, the epidemiology, pathophysiology, diagnosis, and treatment of AITDs are reviewed with an emphasis on the naturopathic clinical management of Hasimoto thyroiditis. Evidence-based herbal therapies indicated for reducing hyperactive immune responses in Hashimoto thyroiditis are also explored.1.5 general CEUs approved by OBNMDiagnosis and Treatment of Multiple SclerosisPresenter: Lynne Shinto, ND, MPHOriginal Date: January 29, 2017Multiple sclerosis (MS) is the most common autoimmune disorder affecting the central nervous system. MS affects approximately 400,000 people in the United States, symptoms can start anywhere from 10-80 years of age. No single test can diagnose MS and currently there is no cure. This presentation reviews MS diagnosis, FDA approved disease modifying therapies, and evidence-based natural therapies.1.5 CEUs (including 1.0 general and 0.5 pharmacy) approved by OBNM